In breast cancer, tumor cells capable of forming tumors in immunocompromised mice (i.e., CSC by a functional definition) are identified by the expression of either the enzyme aldehyde dehydrogenase (ALDH) (5) and/or the CD24−/CD44+ phenotype (6), representing two largely non-overlapping cell populations. This evidence concerns the gene CD44 and breast cancer.